Newco Katama in deal for Sanochemia's tolperisone

Sanochemia Pharmazeutika AG (Xetra:SAC) granted newco Katama Pharmaceuticals Inc. (San Diego, Calif.) exclusive rights in North America to develop and commercialize spasticity product tolperisone. Kat...